NarCoType31 vs Kazuya | 47–28 | 62.67% |
NarCoType31 vs King | 36–27 | 57.14% |
NarCoType31 vs Law | 27–23 | 54.00% |
NarCoType31 vs Jin | 27–20 | 57.45% |
NarCoType31 vs Hwoarang | 20–20 | 50.00% |
NarCoType31 vs Paul | 19–17 | 52.78% |
NarCoType31 vs Yoshimitsu | 13–19 | 40.62% |
NarCoType31 vs Reina | 16–16 | 50.00% |
NarCoType31 vs Bryan | 17–14 | 54.84% |
NarCoType31 vs Lili | 11–18 | 37.93% |
NarCoType31 vs Dragunov | 10–18 | 35.71% |
NarCoType31 vs Jun | 17–11 | 60.71% |
NarCoType31 vs Steve | 14–12 | 53.85% |
NarCoType31 vs Eddy | 11–13–1 | 45.83% |
NarCoType31 vs Devil Jin | 10–9 | 52.63% |
NarCoType31 vs Heihachi | 9–10 | 47.37% |
NarCoType31 vs Nina | 10–7 | 58.82% |
NarCoType31 vs Xiaoyu | 6–10 | 37.50% |
NarCoType31 vs Alisa | 8–5 | 61.54% |
NarCoType31 vs Lee | 10–3 | 76.92% |
NarCoType31 vs Feng | 7–5 | 58.33% |
NarCoType31 vs Victor | 4–7 | 36.36% |
NarCoType31 vs Asuka | 7–3 | 70.00% |
NarCoType31 vs Lars | 4–6 | 40.00% |
NarCoType31 vs Leroy | 7–3 | 70.00% |
NarCoType31 vs Lidia | 5–5 | 50.00% |
NarCoType31 vs Claudio | 5–3 | 62.50% |
NarCoType31 vs Kuma | 4–2 | 66.67% |
NarCoType31 vs Jack-8 | 1–3 | 25.00% |
NarCoType31 vs Zafina | 3–1 | 75.00% |
NarCoType31 vs Azucena | 1–3 | 25.00% |
NarCoType31 vs Raven | 2–1 | 66.67% |
NarCoType31 vs Leo | 2–0 | 100.00% |
NarCoType31 vs Shaheen | 0–2 | 0.00% |
NarCoType31 vs Panda | 0–1 | 0.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.